PDSB logo

PDS Biotechnology (PDSB)

Profile

Full Name

PDS Biotechnology Corporation

Ticker Symbol

PDSB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 30, 2015

Indexes

Not included

Website

http://www.pdsbiotech.com

Employees

24

Key Details

Price

$1.04(-6.31%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.03(+25.90% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.04
PDSB price is $1.04

30-Day Relative Volume

0.47
PDSB 30-day relative volume is 0.47

Price Performance

Price Today change

-6.31%
PDSB price is down -6.31% today

Price YTD change

-36.2%
PDSB price is down -36.2% since January 1st

Price 1-year change

-62.86%
PDSB price is down -62.86% year-on-year

Price 3-year change

-81.43%
PDSB price is down -81.43% over the past 3 years

Price Range

Price All-time high

$517.40
PDSB price is currently -99.80% below its historical high of $517.40

Price 3-year low

$0.85
PDSB price is currently +22.21% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$47.21M
PDSB market capitalization is $47.21 million

Market cap 3-year change

-70.37%
PDSB market capitalization is down -70.37% over the past 3 years

Market cap All-time high

$645.88M
PDSB market capitalization is currently -92.69% below its historical high of $645.88 million

Market cap sector rank

37.25%
PDSB market capitalization is higher than 37.25% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+23.76%
PDSB shares outstanding is up +23.76% year-on-year

Shares Outstanding 3-Year Change

+59.56%
PDSB shares outstanding is up +59.56% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.43
PDSB beta is 1.43

200-day SMA

$2.41
PDSB price is currently -56.89% below its 200-day simple moving average

50-day SMA

$1.28
PDSB price is currently -18.78% below its 50-day simple moving average

RSI

46.62
PDSB 14-day relative strength index is 46.62

Volume

0.47
PDSB 30-day relative volume is 0.47

ATR

$0.12
PDSB average true range is $0.12

10-day Historical Volatility

101.96%
PDSB 10-day historical volatility is 101.96%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
PDSB annual revenue value is unknown

Revenue Analysts estimate

-
PDSB annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
PDSB annual revenue 1-year change is unknown

Revenue Sector rank

-
PDSB annual revenue is unknown

EPS

EPS

-$1.03
PDSB annual earnings per share is -$1.03

EPS Analysts estimate

-$0.95
PDSB annual earnings per share is currently +8.42% higher than the consensus analysts' forecast

EPS 1-year change

+25.9%
PDSB annual earnings per share is up +25.9% year-on-year

EPS Sector rank

55.84%
PDSB annual earnings per share is higher than 55.84% of companies in Healthcare sector

Profit

Gross profit

-
PDSB annual gross profit value is unknown

Gross margin

-
PDSB annual gross profit margin value is unknown

Operating profit

-$36.32M
PDSB annual operating income is -$36.32 million

Operating margin

-
PDSB annual operating profit margin value is unknown

Net income

-$37.61M
PDSB annual net profit is -$37.61 million

Net margin

-
PDSB annual net profit margin value is unknown

Expenses

Total expenses

$36.32M
PDSB annual total expenses is $36.32 million

Operating expenses

$36.32M
PDSB annual total operating expenses is $36.32 million

Cost of goods sold

-
PDSB annual cost of goods sold value is unknown

Selling, general & administrative expenses

$13.76M
PDSB annual SGA is $13.76 million

Depreciation and amortization

$21.10K
PDSB annual depreciation & amortization is $21.10 thousand

Interest expense

$4.67M
PDSB annual interest expense is $4.67 million

Income tax

-$869.20K
PDSB annual income tax is -$869.20 thousand

EBIT & EBITDA

EBIT

-$33.81M
PDSB annual earnings before interest & taxes is -$33.81 million

EBITDA

-$33.79M
PDSB annual EBITDA is -$33.79 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$45.36M
PDSB annual total assets is $45.36 million

Non current assets

$304.20K
PDSB annual long term assets is $304.20 thousand

Current assets

$45.05M
PDSB annual total current assets is $45.05 million

Cash and cash equivalents

$41.69M
PDSB annual cash & cash equivalents is $41.69 million

Accounts receivable

-
PDSB annual accounts receivable value is unknown

Inventory

-
PDSB annual inventory value is unknown

Liabilities

Total liabilities

$26.35M
PDSB annual total liabilities is $26.35 million

Long term liabilities

$9.27M
PDSB annual total long term liabilities is $9.27 million

Current liabilities

$17.09M
PDSB annual total current liabilities is $17.09 million

Accounts payable

$1.68M
PDSB annual accounts payable is $1.68 million

Debt

Total debt

$21.83M
PDSB annual total debt is $21.83 million

Total debt 1-year change

-8.49%
PDSB annual total debt is down -8.49% year-on-year

Long term debt

$9.27M
PDSB annual long term debt is $9.27 million

Short term debt

$12.56M
PDSB annual short term debt is $12.56 million

Equity & Capital

Shareholders equity

$19.00M
PDSB annual stockholders equity is $19.00 million

Book value

$19.00M
PDSB annual book value is $19.00 million

Retained earnings

-$182.11M
PDSB annual retained earnings is -$182.11 million

Working capital

$27.97M
PDSB annual working capital is $27.97 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$35.03M
PDSB annual cash flow from operations is -$35.03 million

Cash from operations 1-year change

-4.14%
PDSB annual cash flow from operations is down -4.14% year-on-year

Cash from investing

-$29.00K
PDSB annual cash flow from investing activities is -$29.00 thousand

Cash from investing 1-year change

-100%
PDSB annual cash flow from investing activities is down -100% year-on-year

Cash from financing

$20.19M
PDSB annual cash flow from financing activities is $20.19 million

Cash from financing 1-year change

+23.28%
PDSB annual cash flow from financing activities is up +23.28% year-on-year

CAPEX

CAPEX

-
PDSB annual capital expenditures value is unknown

CAPEX 1-year change

-
PDSB annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$35.06M
PDSB annual free cash flow is -$35.06 million

Free cash flow 1-year change

-4.23%
PDSB annual free cash flow is down -4.23% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
PDSB annual gross profit margin value is unknown

Operating margin

-
PDSB annual operating profit margin value is unknown

Net margin

-
PDSB annual net profit margin value is unknown

ROA & ROE

ROA

-82.92%
PDSB annual return on assets is -82.92%

ROE

-197.90%
PDSB annual return on equity is -197.90%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PDSB price to earnings ratio value is unknown

PE ratio Sector rank

-
PDSB price to earnings ratio is unknown

PB Ratio

PB ratio

2.48
PDSB price to book ratio is 2.48

PB ratio Sector rank

68.89%
PDSB price to book ratio is higher than 68.89% of companies in Healthcare sector

PS Ratio

PS ratio

-
PDSB price to sales ratio value is unknown

PS ratio Sector rank

-
PDSB price to sales ratio is unknown

Enterprise value

Enterprise value

$27.35M
PDSB enterprise value is $27.35 million

Enterprise value Sector rank

34.49%
PDSB enterprise value is higher than 34.49% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.81
PDSB EV/EBITDA is -0.81

EV/EBITDA Sector rank

45.95%
PDSB EV/EBITDA is higher than 45.95% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.64
PDSB annual current ratio is 2.64

Quick ratio

-
PDSB annual quick ratio value is unknown

Leverage

Debt to equity

1.15
PDSB annual debt to equity ratio is 1.15

Interest coverage ratio

-7.23
PDSB annual interest coverage ratio is -7.23

Risk & Stability

Piotroski F-Score

-
PDSB piotroski f-score value is unknown

Altman Z-Score

-
PDSB altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 27, 25 HC Wainwright & Co.
Buy
Mar 13, 25 HC Wainwright & Co.
Buy
Mar 7, 25 HC Wainwright & Co.
Buy
Feb 24, 25 HC Wainwright & Co.
Buy
Dec 18, 24 HC Wainwright & Co.
Buy
Nov 25, 24 B. Riley Securities
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Oct 24, 24 HC Wainwright & Co.
Buy
Oct 2, 24 HC Wainwright & Co.
Buy
Sep 17, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

CTMX logo
CytomX Therapeutics (CTMX)
GANX logo
Gain Therapeutics (GANX)
EDAP logo
EDAP TMS SA (EDAP)
SER logo
Serina Therapeutics (SER)
ALVR logo
AlloVir (ALVR)
CUE logo
Cue Biopharma (CUE)
ONCY logo
Oncolytics Biotech (ONCY)
ZOM logo
Zomedica (ZOM)
ACET logo
Adicet Bio (ACET)
  • What is the ticker symbol for PDS Biotechnology?
  • Does PDS Biotechnology pay dividends?
  • What sector is PDS Biotechnology in?
  • What industry is PDS Biotechnology in?
  • What country is PDS Biotechnology based in?
  • When did PDS Biotechnology go public?
  • Is PDS Biotechnology in the S&P 500?
  • Is PDS Biotechnology in the NASDAQ 100?
  • Is PDS Biotechnology in the Dow Jones?
  • When was PDS Biotechnology's last earnings report?
  • When does PDS Biotechnology report earnings?
  • Should I buy PDS Biotechnology stock now?

What is the ticker symbol for PDS Biotechnology?

The ticker symbol for PDS Biotechnology is NASDAQ:PDSB

Does PDS Biotechnology pay dividends?

No, PDS Biotechnology does not pay dividends

What sector is PDS Biotechnology in?

PDS Biotechnology is in the Healthcare sector

What industry is PDS Biotechnology in?

PDS Biotechnology is in the Biotechnology industry

What country is PDS Biotechnology based in?

PDS Biotechnology is headquartered in United States

When did PDS Biotechnology go public?

PDS Biotechnology's initial public offering (IPO) was on September 30, 2015

Is PDS Biotechnology in the S&P 500?

No, PDS Biotechnology is not included in the S&P 500 index

Is PDS Biotechnology in the NASDAQ 100?

No, PDS Biotechnology is not included in the NASDAQ 100 index

Is PDS Biotechnology in the Dow Jones?

No, PDS Biotechnology is not included in the Dow Jones index

When was PDS Biotechnology's last earnings report?

PDS Biotechnology's most recent earnings report was on Mar 27, 2025

When does PDS Biotechnology report earnings?

The next expected earnings date for PDS Biotechnology is May 15, 2025

Should I buy PDS Biotechnology stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page